We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medgenics | LSE:MEDU | London | Ordinary Share | COM SHS USD0.0001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 392.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/7/2012 08:25 | Good share price runs always come to an end | saturn5 | |
10/7/2012 21:15 | Note the vote | sueyou1 | |
09/7/2012 21:09 | PDT, a big congratulations for hitting your targets and best wishes in the future. Paul and kalinit, thank you for your kind words. | sicilian_kan | |
09/7/2012 21:01 | Well said Paul. Without SK and his in depth, astute, accurate research I would never have had the confidence to invest in this share so much. It is and will be life changing for us who have backed the company and those who will be treated by this amazing technology. Glad you enjoyed the ride. Those of us staying on the train - lets see how far she will go. Pearlman's most recent resume of the company in an interview on Proactive Investor gives a measure of its potential - never seen him quite to excited. He clearly feels they have the scoop of the century with Sol at the helm. | kalinit | |
09/7/2012 19:50 | Thanks again to Sicilian Kan for this excellent thread. I have now sold my holding but will watch with interest from the sidelines. Its been a very good run and may well move much higher but I have hit my targets and the saying of "always leave something for the next investor" is a good one. Good luck all. Paul | pdt | |
07/7/2012 23:52 | No point in comparing MCaps, the companies and products are completely different, the products and technologies have to be different or there would be no such thing as Patent protection, the companies are different because the management, BOD, scientists etc are all different. What cash/debt does each company have? What is the level of profit/loss for each company? What is the P/E and other financial ratios of each company? What are the markets and market values for each company? Without comparing these items the comparison on MCap is totally meaningless ramping. | sueyou1 | |
06/7/2012 10:37 | an old post of mine: (comparing market caps with peer companies) andrbea - 25 Jun 2012 - 20:00:26 - 263 of 296 So taking those slightly old figures: idix at 1 billion plays medu at 69 million = 14 times our mkt cap achn at 471 mn = 6.8 times our mkt cap | andrbea | |
06/7/2012 08:35 | OT thanks,however I am interested, as big potential market in far east imo .... and basic needs for people,sanitary ware ,hand basins | hazl | |
06/7/2012 08:29 | achp doesn't excite me as wall or ceiling tiles isn't exciting (potential growth) as an oil or pharma stock but each to his own good luck. | andrbea | |
06/7/2012 08:09 | OT andrbea can I ask your opinion on achp? | hazl | |
06/7/2012 07:48 | so the link above (post 287) says target price 30$, that's 100% higher than 15$ ../ We continue to predict a short-term stock price of $30 given the markets for the Biopump technology and feel that long-term this number may actually be conservative. | andrbea | |
05/7/2012 21:26 | $15 on .475M traded! | matt123d | |
05/7/2012 19:17 | shes gone to hit £7.50 a share this mth buy buy buy | jammytass | |
05/7/2012 19:01 | Hitting new highs in the US at the moment. Could be partly related to the appointment of a new chairman who held senior roles at Celgene. | pdt | |
29/6/2012 19:35 | I'd say BIG price rises/falls will be dictated primarily by the results of trials and any new partnerships. Or do you think you can affect the price by posting childish drivel here, Sue? Luv ya, baby! | britishb | |
29/6/2012 17:33 | Another 1pm rise, guess it's the USA rampers again ;-) Director exercise of options? to sell that stock at a nice profit perhaps? | sueyou1 | |
29/6/2012 15:37 | 28 June 2012 | 14:43pm StockMarketWire.com - Medgenics has issued 4,286 shares following the exercise of options by director Joel Kanter. | andrbea | |
29/6/2012 15:26 | on the up again!!! | jammytass | |
29/6/2012 15:26 | on the up again!!! | jammytass | |
28/6/2012 21:49 | Sue, Queen of Shorts, stopped out of a ridiculous short! lolol | britishb | |
28/6/2012 19:09 | Down-doobie-do-down- | sueyou1 |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions